

A 21-year-old bioengineering student diagnosed with a rare muscle disease at 13 is now engineering a potential cure for herself and nearly 1 million others worldwide.

Héloïse Hoffmann just won a $100,000 fellowship to advance her groundbreaking gene therapy research.

Want to know more?